{"frames":[],"tokens":["Acta","neuropathologica","."]}
{"frames":[{"target":{"name":"Relative_time","spans":[{"start":5,"end":6,"text":"subsequent"}]},"annotationSets":[{"rank":0,"score":18.54238681386274,"frameElements":[]}]},{"target":{"name":"Duplication","spans":[{"start":6,"end":7,"text":"copy"}]},"annotationSets":[{"rank":0,"score":66.47021567327722,"frameElements":[{"name":"Copy","spans":[{"start":6,"end":7,"text":"copy"}]}]}]},{"target":{"name":"Quantity","spans":[{"start":7,"end":8,"text":"number"}]},"annotationSets":[{"rank":0,"score":24.095609561197794,"frameElements":[{"name":"Quantity","spans":[{"start":7,"end":8,"text":"number"}]}]}]},{"target":{"name":"Scrutiny","spans":[{"start":8,"end":9,"text":"analysis"}]},"annotationSets":[{"rank":0,"score":44.54974187595288,"frameElements":[{"name":"Ground","spans":[{"start":7,"end":8,"text":"number"}]}]}]},{"target":{"name":"Body_decoration","spans":[{"start":14,"end":15,"text":"basis"}]},"annotationSets":[{"rank":0,"score":24.768424556309476,"frameElements":[]}]},{"target":{"name":"Natural_features","spans":[{"start":18,"end":19,"text":"integrated"}]},"annotationSets":[{"rank":0,"score":32.64488220632861,"frameElements":[{"name":"Locale","spans":[{"start":18,"end":19,"text":"integrated"}]}]}]},{"target":{"name":"Means","spans":[{"start":21,"end":22,"text":"approach"}]},"annotationSets":[{"rank":0,"score":20.795845013396356,"frameElements":[{"name":"Means","spans":[{"start":21,"end":22,"text":"approach"}]}]}]},{"target":{"name":"People_by_age","spans":[{"start":23,"end":24,"text":"adult"}]},"annotationSets":[{"rank":0,"score":28.183630818271208,"frameElements":[{"name":"Person","spans":[{"start":23,"end":24,"text":"adult"}]}]}]}],"tokens":["ATRX","and","IDH1-R132H","immunohistochemistry","with","subsequent","copy","number","analysis","and","IDH","sequencing","as","a","basis","for","an","``","integrated","''","diagnostic","approach","for","adult","astrocytoma",",","oligodendroglioma","and","glioblastoma","."]}
{"frames":[{"target":{"name":"Communicate_categorization","spans":[{"start":3,"end":4,"text":"represented"}]},"annotationSets":[{"rank":0,"score":46.91065082564859,"frameElements":[{"name":"Item","spans":[{"start":0,"end":2,"text":"Diffuse gliomas"}]},{"name":"Category","spans":[{"start":4,"end":25,"text":"in the 2007 WHO classification as astrocytomas , oligoastrocytomas and oligodendrogliomas of grades II and III and glioblastomas WHO grade IV"}]}]}]},{"target":{"name":"Categorization","spans":[{"start":8,"end":9,"text":"classification"}]},"annotationSets":[{"rank":0,"score":47.02876576095262,"frameElements":[{"name":"Item","spans":[{"start":5,"end":7,"text":"the 2007"}]},{"name":"Category","spans":[{"start":9,"end":25,"text":"as astrocytomas , oligoastrocytomas and oligodendrogliomas of grades II and III and glioblastomas WHO grade IV"}]}]}]}],"tokens":["Diffuse","gliomas","are","represented","in","the","2007","WHO","classification","as","astrocytomas",",","oligoastrocytomas","and","oligodendrogliomas","of","grades","II","and","III","and","glioblastomas","WHO","grade","IV","."]}
{"frames":[{"target":{"name":"Medical_conditions","spans":[{"start":4,"end":5,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":37.257935165396205,"frameElements":[]}]},{"target":{"name":"Being_obligated","spans":[{"start":5,"end":6,"text":"have"}]},"annotationSets":[{"rank":0,"score":20.536701048056,"frameElements":[{"name":"Responsible_party","spans":[{"start":0,"end":5,"text":"Molecular data on these tumors"}]}]}]},{"target":{"name":"Importance","spans":[{"start":7,"end":8,"text":"major"}]},"annotationSets":[{"rank":0,"score":54.00223155241852,"frameElements":[{"name":"Factor","spans":[{"start":8,"end":9,"text":"impact"}]}]}]},{"target":{"name":"Objective_influence","spans":[{"start":8,"end":9,"text":"impact"}]},"annotationSets":[{"rank":0,"score":36.64639112210526,"frameElements":[{"name":"Dependent_entity","spans":[{"start":9,"end":16,"text":"on prognosis and therapy of the patients"}]},{"name":"Degree","spans":[{"start":7,"end":8,"text":"major"}]}]}]},{"target":{"name":"Cure","spans":[{"start":12,"end":13,"text":"therapy"}]},"annotationSets":[{"rank":0,"score":44.43086878230764,"frameElements":[]}]}],"tokens":["Molecular","data","on","these","tumors","have","a","major","impact","on","prognosis","and","therapy","of","the","patients","."]}
{"frames":[{"target":{"name":"Terms_of_agreement","spans":[{"start":6,"end":7,"text":"parameters"}]},"annotationSets":[{"rank":0,"score":14.15041269575043,"frameElements":[{"name":"Requirements","spans":[{"start":6,"end":7,"text":"parameters"}]},{"name":"Descriptor","spans":[{"start":5,"end":6,"text":"molecular"}]}]}]},{"target":{"name":"Communicate_categorization","spans":[{"start":10,"end":11,"text":"definition"}]},"annotationSets":[{"rank":0,"score":42.50040295649587,"frameElements":[{"name":"Item","spans":[{"start":11,"end":14,"text":"of brain tumors"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":13,"end":14,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":34.35232136325519,"frameElements":[]}]},{"target":{"name":"Purpose","spans":[{"start":16,"end":17,"text":"planned"}]},"annotationSets":[{"rank":0,"score":36.35017039339998,"frameElements":[{"name":"Goal","spans":[{"start":10,"end":14,"text":"definition of brain tumors"}]}]}]},{"target":{"name":"Sending","spans":[{"start":20,"end":21,"text":"forwarded"}]},"annotationSets":[{"rank":0,"score":55.41586223900388,"frameElements":[{"name":"Theme","spans":[{"start":22,"end":27,"text":"the `` ISN-Haarlem '' consensus"}]}]}]}],"tokens":["Consequently",",","the","inclusion","of","molecular","parameters","in","the","WHO","definition","of","brain","tumors","is","being","planned","and","has","been","forwarded","as","the","``","ISN-Haarlem","''","consensus","."]}
{"frames":[{"target":{"name":"Locative_relation","spans":[{"start":2,"end":3,"text":"here"}]},"annotationSets":[{"rank":0,"score":27.560332476094754,"frameElements":[{"name":"Ground","spans":[{"start":2,"end":3,"text":"here"}]}]}]},{"target":{"name":"Scrutiny","spans":[{"start":4,"end":5,"text":"analyze"}]},"annotationSets":[{"rank":0,"score":42.350007585037034,"frameElements":[{"name":"Cognizer","spans":[{"start":0,"end":1,"text":"We"}]}]}]},{"target":{"name":"Emotion_directed","spans":[{"start":8,"end":9,"text":"interest"}]},"annotationSets":[{"rank":0,"score":67.08968256074114,"frameElements":[{"name":"Experiencer","spans":[{"start":7,"end":8,"text":"special"}]}]}]},{"target":{"name":"Inclusion","spans":[{"start":9,"end":10,"text":"including"}]},"annotationSets":[{"rank":0,"score":43.37945708949823,"frameElements":[{"name":"Part","spans":[{"start":10,"end":23,"text":"ATRX , IDH and 1p/19q codeletion in a series of 405 adult patients"}]},{"name":"Total","spans":[{"start":7,"end":9,"text":"special interest"}]}]}]},{"target":{"name":"Sequence","spans":[{"start":18,"end":19,"text":"series"}]},"annotationSets":[{"rank":0,"score":15.641429519935318,"frameElements":[{"name":"Entities","spans":[{"start":19,"end":23,"text":"of 405 adult patients"}]}]}]},{"target":{"name":"People_by_age","spans":[{"start":21,"end":22,"text":"adult"}]},"annotationSets":[{"rank":0,"score":27.84575030574242,"frameElements":[{"name":"Person","spans":[{"start":21,"end":22,"text":"adult"}]}]}]}],"tokens":["We",",","here",",","analyze","markers","of","special","interest","including","ATRX",",","IDH","and","1p/19q","codeletion","in","a","series","of","405","adult","patients","."]}
{"frames":[{"target":{"name":"Categorization","spans":[{"start":4,"end":5,"text":"classified"}]},"annotationSets":[{"rank":0,"score":41.834374151568184,"frameElements":[{"name":"Cognizer","spans":[{"start":3,"end":4,"text":"2007"}]},{"name":"Item","spans":[{"start":2,"end":3,"text":"WHO"}]},{"name":"Category","spans":[{"start":5,"end":18,"text":"tumors were 152 astrocytomas , 61 oligodendrogliomas , 63 oligoastrocytomas and 129 glioblastomas"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":5,"end":6,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":36.396816614044745,"frameElements":[]}]}],"tokens":["Among","the","WHO","2007","classified","tumors","were","152","astrocytomas",",","61","oligodendrogliomas",",","63","oligoastrocytomas","and","129","glioblastomas","."]}
{"frames":[{"target":{"name":"Relative_time","spans":[{"start":0,"end":1,"text":"Following"}]},"annotationSets":[{"rank":0,"score":19.14462330827952,"frameElements":[{"name":"Landmark_occasion","spans":[{"start":1,"end":8,"text":"the concepts of the `` ISN-Haarlem ''"}]}]}]},{"target":{"name":"Sequence","spans":[{"start":12,"end":13,"text":"series"}]},"annotationSets":[{"rank":0,"score":14.257532349496554,"frameElements":[{"name":"Entities","spans":[{"start":13,"end":18,"text":"to obtain `` integrated ''"}]}]}]},{"target":{"name":"Getting","spans":[{"start":14,"end":15,"text":"obtain"}]},"annotationSets":[{"rank":0,"score":57.12297686655117,"frameElements":[{"name":"Recipient","spans":[{"start":11,"end":13,"text":"the series"}]},{"name":"Theme","spans":[{"start":16,"end":18,"text":"integrated ''"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":21,"end":22,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":34.65429355636038,"frameElements":[]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":25,"end":26,"text":"100"}]},"annotationSets":[{"rank":0,"score":31.901779843388606,"frameElements":[{"name":"Number","spans":[{"start":25,"end":26,"text":"100"}]},{"name":"Entity","spans":[{"start":26,"end":27,"text":"oligodendrogliomas"}]}]}]}],"tokens":["Following","the","concepts","of","the","``","ISN-Haarlem","''",",","we","rediagnosed","the","series","to","obtain","``","integrated","''","diagnoses","with","155","tumors","being","astrocytomas",",","100","oligodendrogliomas","and","150","glioblastomas","."]}
{"frames":[{"target":{"name":"Weapon","spans":[{"start":2,"end":3,"text":"subset"}]},"annotationSets":[{"rank":0,"score":46.406402561103135,"frameElements":[{"name":"Weapon","spans":[{"start":2,"end":3,"text":"subset"}]}]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":4,"end":5,"text":"100"}]},"annotationSets":[{"rank":0,"score":29.781874855922634,"frameElements":[{"name":"Number","spans":[{"start":4,"end":5,"text":"100"}]},{"name":"Entity","spans":[{"start":6,"end":7,"text":"gliomas"}]}]}]},{"target":{"name":"Trial","spans":[{"start":10,"end":11,"text":"trial"}]},"annotationSets":[{"rank":0,"score":41.25543878991535,"frameElements":[{"name":"Defendant","spans":[{"start":9,"end":10,"text":"NOA-04"}]}]}]},{"target":{"name":"Possession","spans":[{"start":22,"end":23,"text":"had"}]},"annotationSets":[{"rank":0,"score":39.2907862116472,"frameElements":[{"name":"Possession","spans":[{"start":23,"end":37,"text":"a significantly greater prognostic power for overall and progression-free survival compared to WHO 2007"}]},{"name":"Owner","spans":[{"start":17,"end":22,"text":"the `` integrated '' diagnosis"}]}]}]},{"target":{"name":"Leadership","spans":[{"start":27,"end":28,"text":"power"}]},"annotationSets":[{"rank":0,"score":56.54510189909085,"frameElements":[{"name":"Leader","spans":[{"start":21,"end":22,"text":"diagnosis"}]},{"name":"Type","spans":[{"start":26,"end":27,"text":"prognostic"}]}]}]},{"target":{"name":"Clothing","spans":[{"start":29,"end":30,"text":"overall"}]},"annotationSets":[{"rank":0,"score":34.58456035740788,"frameElements":[]}]},{"target":{"name":"Surviving","spans":[{"start":32,"end":33,"text":"survival"}]},"annotationSets":[{"rank":0,"score":14.406490177736437,"frameElements":[]}]},{"target":{"name":"Evaluative_comparison","spans":[{"start":33,"end":34,"text":"compared"}]},"annotationSets":[{"rank":0,"score":25.203583409350593,"frameElements":[{"name":"Standard_item","spans":[{"start":34,"end":37,"text":"to WHO 2007"}]},{"name":"Profiled_attribute","spans":[{"start":32,"end":33,"text":"survival"}]}]}]}],"tokens":["In","a","subset","of","100","diffuse","gliomas","from","the","NOA-04","trial","with","long-term","follow-up","data","available",",","the","``","integrated","''","diagnosis","had","a","significantly","greater","prognostic","power","for","overall","and","progression-free","survival","compared","to","WHO","2007","."]}
{"frames":[{"target":{"name":"Locale_by_use","spans":[{"start":4,"end":5,"text":"integrated"}]},"annotationSets":[{"rank":0,"score":35.57954164210405,"frameElements":[{"name":"Locale","spans":[{"start":4,"end":5,"text":"integrated"}]}]}]},{"target":{"name":"Beat_opponent","spans":[{"start":8,"end":9,"text":"loss"}]},"annotationSets":[{"rank":0,"score":102.11591449485992,"frameElements":[]}]},{"target":{"name":"Encoding","spans":[{"start":11,"end":12,"text":"expression"}]},"annotationSets":[{"rank":0,"score":17.128199466612145,"frameElements":[]}]},{"target":{"name":"Social_connection","spans":[{"start":13,"end":14,"text":"close"}]},"annotationSets":[{"rank":0,"score":10.37903073563617,"frameElements":[{"name":"Individual1","spans":[{"start":0,"end":12,"text":"Based on the `` integrated '' diagnoses , loss of ATRX expression"}]},{"name":"Individual2","spans":[{"start":14,"end":32,"text":"to being mutually exclusive to 1p/19q codeletion , with only 2 of 167 ATRX-negative tumors exhibiting 1p/19q codeletion"}]},{"name":"Degree","spans":[{"start":13,"end":14,"text":"close"}]}]}]},{"target":{"name":"Sole_instance","spans":[{"start":23,"end":24,"text":"only"}]},"annotationSets":[{"rank":0,"score":4.071066066560645,"frameElements":[{"name":"Type","spans":[{"start":24,"end":32,"text":"2 of 167 ATRX-negative tumors exhibiting 1p/19q codeletion"}]}]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":24,"end":25,"text":"2"}]},"annotationSets":[{"rank":0,"score":19.68905478923095,"frameElements":[{"name":"Number","spans":[{"start":24,"end":25,"text":"2"}]},{"name":"Entity","spans":[{"start":25,"end":32,"text":"of 167 ATRX-negative tumors exhibiting 1p/19q codeletion"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":28,"end":29,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":32.802261027151964,"frameElements":[]}]},{"target":{"name":"Evidence","spans":[{"start":29,"end":30,"text":"exhibiting"}]},"annotationSets":[{"rank":0,"score":28.39726782842538,"frameElements":[{"name":"Proposition","spans":[{"start":30,"end":32,"text":"1p/19q codeletion"}]}]}]}],"tokens":["Based","on","the","``","integrated","''","diagnoses",",","loss","of","ATRX","expression","was","close","to","being","mutually","exclusive","to","1p/19q","codeletion",",","with","only","2","of","167","ATRX-negative","tumors","exhibiting","1p/19q","codeletion","."]}
{"frames":[{"target":{"name":"Quantity","spans":[{"start":0,"end":1,"text":"All"}]},"annotationSets":[{"rank":0,"score":21.893824041396307,"frameElements":[{"name":"Quantity","spans":[{"start":0,"end":1,"text":"All"}]}]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":2,"end":3,"text":"4"}]},"annotationSets":[{"rank":0,"score":23.96519872141326,"frameElements":[{"name":"Number","spans":[{"start":2,"end":3,"text":"4"}]}]}]},{"target":{"name":"Beat_opponent","spans":[{"start":7,"end":8,"text":"loss"}]},"annotationSets":[{"rank":0,"score":102.11591449485992,"frameElements":[]}]},{"target":{"name":"Encoding","spans":[{"start":10,"end":11,"text":"expression"}]},"annotationSets":[{"rank":0,"score":15.257077421271223,"frameElements":[]}]},{"target":{"name":"Intentionally_act","spans":[{"start":14,"end":15,"text":"carried"}]},"annotationSets":[{"rank":0,"score":72.43767089285708,"frameElements":[{"name":"Act","spans":[{"start":15,"end":20,"text":"either IDH1 or IDH2 mutations"}]}]}]}],"tokens":["All","but","4","of","141","patients","with","loss","of","ATRX","expression","and","diffuse","glioma","carried","either","IDH1","or","IDH2","mutations","."]}
{"frames":[{"target":{"name":"Beat_opponent","spans":[{"start":8,"end":9,"text":"loss"}]},"annotationSets":[{"rank":0,"score":102.11591449485992,"frameElements":[]}]},{"target":{"name":"Encoding","spans":[{"start":11,"end":12,"text":"expression"}]},"annotationSets":[{"rank":0,"score":17.128199466612145,"frameElements":[]}]},{"target":{"name":"Quantity","spans":[{"start":13,"end":14,"text":"no"}]},"annotationSets":[{"rank":0,"score":24.669684622786342,"frameElements":[{"name":"Quantity","spans":[{"start":13,"end":14,"text":"no"}]}]}]},{"target":{"name":"Evidence","spans":[{"start":16,"end":17,"text":"exhibited"}]},"annotationSets":[{"rank":0,"score":30.422698651316736,"frameElements":[{"name":"Proposition","spans":[{"start":17,"end":20,"text":"an H3F3A mutation"}]},{"name":"Support","spans":[{"start":2,"end":16,"text":"the majority of glioblastoma patients with loss of ATRX expression but no IDH mutations"}]}]}]}],"tokens":["Interestingly",",","the","majority","of","glioblastoma","patients","with","loss","of","ATRX","expression","but","no","IDH","mutations","exhibited","an","H3F3A","mutation","."]}
{"frames":[{"target":{"name":"Increment","spans":[{"start":0,"end":1,"text":"Further"}]},"annotationSets":[{"rank":0,"score":13.801126675195235,"frameElements":[{"name":"Class","spans":[{"start":2,"end":7,"text":"all patients with 1p/19 codeletion"}]}]}]},{"target":{"name":"Quantity","spans":[{"start":2,"end":3,"text":"all"}]},"annotationSets":[{"rank":0,"score":25.982536612356277,"frameElements":[{"name":"Quantity","spans":[{"start":2,"end":3,"text":"all"}]},{"name":"Individuals","spans":[{"start":3,"end":4,"text":"patients"}]}]}]},{"target":{"name":"Intentionally_act","spans":[{"start":7,"end":8,"text":"carried"}]},"annotationSets":[{"rank":0,"score":65.27689168342415,"frameElements":[{"name":"Act","spans":[{"start":8,"end":10,"text":"a mutation"}]},{"name":"Agent","spans":[{"start":2,"end":7,"text":"all patients with 1p/19 codeletion"}]}]}]}],"tokens":["Further",",","all","patients","with","1p/19","codeletion","carried","a","mutation","in","IDH1","or","IDH2","."]}
{"frames":[{"target":{"name":"Presence","spans":[{"start":1,"end":2,"text":"present"}]},"annotationSets":[{"rank":0,"score":6.165475396248212,"frameElements":[{"name":"Entity","spans":[{"start":0,"end":1,"text":"We"}]}]}]},{"target":{"name":"Scrutiny","spans":[{"start":7,"end":8,"text":"analysis"}]},"annotationSets":[{"rank":0,"score":46.114837509392835,"frameElements":[]}]},{"target":{"name":"Version_sequence","spans":[{"start":9,"end":10,"text":"initial"}]},"annotationSets":[{"rank":0,"score":8.483942566476758,"frameElements":[{"name":"Item","spans":[{"start":10,"end":11,"text":"immunohistochemistry"}]}]}]},{"target":{"name":"Relative_time","spans":[{"start":15,"end":16,"text":"followed"}]},"annotationSets":[{"rank":0,"score":17.74783136916012,"frameElements":[]}]},{"target":{"name":"Scrutiny","spans":[{"start":18,"end":19,"text":"analysis"}]},"annotationSets":[{"rank":0,"score":49.14893855814056,"frameElements":[]}]},{"target":{"name":"Relative_time","spans":[{"start":19,"end":20,"text":"followed"}]},"annotationSets":[{"rank":0,"score":12.383746508761408,"frameElements":[{"name":"Focal_occasion","spans":[{"start":17,"end":19,"text":"1p/19q analysis"}]},{"name":"Landmark_occasion","spans":[{"start":20,"end":43,"text":"by IDH sequencing which reduces the number of molecular analyses and which has a far better association with patient outcome than WHO 2007"}]}]}]},{"target":{"name":"Cause_change_of_position_on_a_scale","spans":[{"start":24,"end":25,"text":"reduces"}]},"annotationSets":[{"rank":0,"score":62.02982816916488,"frameElements":[{"name":"Agent","spans":[{"start":23,"end":24,"text":"which"}]},{"name":"Attribute","spans":[{"start":25,"end":30,"text":"the number of molecular analyses"}]}]}]},{"target":{"name":"Quantity","spans":[{"start":26,"end":27,"text":"number"}]},"annotationSets":[{"rank":0,"score":20.936466125981962,"frameElements":[{"name":"Quantity","spans":[{"start":26,"end":27,"text":"number"}]},{"name":"Individuals","spans":[{"start":27,"end":30,"text":"of molecular analyses"}]}]}]},{"target":{"name":"Scrutiny","spans":[{"start":29,"end":30,"text":"analyses"}]},"annotationSets":[{"rank":0,"score":50.84878980556935,"frameElements":[]}]},{"target":{"name":"Inclusion","spans":[{"start":32,"end":33,"text":"has"}]},"annotationSets":[{"rank":0,"score":29.021532027488234,"frameElements":[{"name":"Part","spans":[{"start":33,"end":43,"text":"a far better association with patient outcome than WHO 2007"}]},{"name":"Total","spans":[{"start":25,"end":30,"text":"the number of molecular analyses"}]}]}]},{"target":{"name":"People_along_political_spectrum","spans":[{"start":34,"end":35,"text":"far"}]},"annotationSets":[{"rank":0,"score":8.29177694079159,"frameElements":[{"name":"Individual","spans":[{"start":34,"end":35,"text":"far"}]}]}]},{"target":{"name":"Desirability","spans":[{"start":35,"end":36,"text":"better"}]},"annotationSets":[{"rank":0,"score":31.540703940288132,"frameElements":[{"name":"Evaluee","spans":[{"start":36,"end":37,"text":"association"}]},{"name":"Degree","spans":[{"start":34,"end":35,"text":"far"}]}]}]},{"target":{"name":"Aggregate","spans":[{"start":36,"end":37,"text":"association"}]},"annotationSets":[{"rank":0,"score":25.68975888075024,"frameElements":[{"name":"Aggregate","spans":[{"start":36,"end":37,"text":"association"}]}]}]},{"target":{"name":"Rashness","spans":[{"start":38,"end":39,"text":"patient"}]},"annotationSets":[{"rank":0,"score":4.659703380628872,"frameElements":[]}]}],"tokens":["We","present","an","algorithm","based","on","stepwise","analysis","with","initial","immunohistochemistry","for","ATRX","and","IDH1-R132H","followed","by","1p/19q","analysis","followed","by","IDH","sequencing","which","reduces","the","number","of","molecular","analyses","and","which","has","a","far","better","association","with","patient","outcome","than","WHO","2007","."]}
